Post-Infectious Irritable Bowel Syndrome (PI-IBS)
This patient most likely has post-infectious irritable bowel syndrome (PI-IBS), which develops in approximately 10% of patients following acute infectious gastroenteritis and presents with the exact symptom constellation described here. 1
Clinical Reasoning
The timeline is classic: viral prodrome six weeks ago, followed by persistent GI symptoms (nausea, vomiting, diarrhea) lasting one month. This fits the established pattern where PI-IBS symptoms emerge immediately after resolution of acute infectious gastroenteritis 1. The patient's demographic profile (33-year-old female) aligns with known risk factors, as female gender and younger age are strongly associated with PI-IBS development 1.
Critical Alarm Feature: Weight Loss
However, this patient requires urgent further investigation because she has significant unintentional weight loss, which is an alarm symptom that mandates exclusion of organic disease before accepting a PI-IBS diagnosis. 1
The Rome Foundation guidelines explicitly state that >10% weight loss requires further investigations beyond standard PI-IBS workup 1. This alarm feature raises the differential diagnosis beyond functional disorders.
Expanded Differential Diagnosis
Given the alarm symptom of weight loss, consider:
Most Likely Diagnoses:
Post-infectious IBS with overlapping post-infectious functional dyspepsia (PI-FD): Up to 44% of PI-IBS patients also meet criteria for PI-FD, which includes nausea and vomiting 1. However, weight loss of this magnitude is atypical.
Post-viral gastroparesis: Young, previously healthy patients can develop gastroparesis after viral illness, presenting with persistent nausea, vomiting, and epigastric pain. This condition has an excellent prognosis with complete resolution in most cases 2. The mean onset is 4.5 days after viral illness resolution 2.
Must-Exclude Diagnoses (Given Weight Loss):
- Microscopic colitis: Should be excluded via colonoscopy with biopsies in IBS-D patients, especially with alarm features 3
- Bile acid diarrhea (BAD): Affects 25-33% of suspected IBS-D patients 3
- Celiac disease: Standard screening required
- Inflammatory bowel disease: Fecal calprotectin and colonoscopy if elevated 3
Rare but Important Considerations:
- Whipple's disease: Chronic diarrhea, weight loss, and fatigue in this age group, though uncommon 4
- Chronic infections (in endemic areas with appropriate exposure history) 5
Recommended Diagnostic Approach
Immediate workup should include:
Laboratory testing:
- Complete blood count
- C-reactive protein
- Fecal calprotectin (if ≥250 μg/g, proceed directly to colonoscopy; if 100-249 μg/g, repeat off NSAIDs/PPIs) 3
- Celiac serology (tissue transglutaminase IgA with total IgA)
- Thyroid function tests
If diarrhea-predominant symptoms:
- Consider SeHCAT scan or serum 7α-hydroxy-4-cholesten-3-one for bile acid diarrhea 3
- Stool studies if not already completed
If nausea/vomiting predominate:
- Gastric emptying study to evaluate for gastroparesis 2
- Upper endoscopy if symptoms persist or worsen
Colonoscopy with biopsies is warranted given the weight loss alarm feature, even if fecal calprotectin is normal, to exclude microscopic colitis and IBD 3
Common Pitfalls to Avoid
Do not diagnose PI-IBS without excluding organic disease when alarm features are present. The guidelines are clear that significant weight loss requires further investigation 1.
Do not assume all post-viral GI symptoms are PI-IBS. Post-viral gastroparesis presents similarly but requires different management 2.
Do not perform colonoscopy reflexively in typical PI-IBS without alarm features, as the yield is extremely low and provides no reassurance benefit 3. However, this patient's weight loss changes the calculus.
Prognosis Considerations
If this proves to be PI-IBS after organic disease exclusion, reassure the patient that symptoms typically improve over time, with better prognosis than non-post-infectious IBS 1. Five of seven patients with post-viral gastroparesis had complete resolution, and two had considerable improvement over 32 months of follow-up 2.
The 4.2-fold increased risk of developing IBS after infectious enteritis decreases to 2.3-fold after 12 months, suggesting natural improvement 1.